Clinical aspects of antimicrobial prophylaxis for invasive urological procedures

References

• Naber KG, Schaeffer AJ, Hynes CF, Matsumoto T, Shoskes DA, Bjerklund Johansen TE (editors). EAU/International consultation on urological infections. Arnhem: European Association of Urology; 2010.
   Google Scholar
• Grabe M. Controversies in antibiotic prophylaxis in urology. Int J Antimicrob Agents. 2004;23(Suppl 1):S17–S23.
   PubMedGoogle Scholar
• Wagenlehner FM, Wagenlehner C, Schinzel S, Naber KG, Working Group ‘Urological Infections’ of German Society of Urology. Working Group ‘Urological Infections’ of German Society of Urology. Prospective, randomized, multicentric, open, comparative study on the efficacy of a prophylactic single dose of 500 mg levofloxacin versus 1920 mg trimethoprim/sulfamethoxazole versus a control group in patients undergoing TUR of the prostate. Eur Urol. 2005;47(4):549–56.
   PubMed Web of Science ®Google Scholar
• Grabe M, Forsgren A, Björk T, Hellsten S. Controlled trial of a short and a prolonged course with ciprofloxacin in patients undergoing transurethral prostatic surgery. Eur J Clin Microbiol. 1987;6(1):11–7.
   PubMedGoogle Scholar
• Adam D, Daschner F. [Prevention of infection in surgery: hygienic measurements and antibiotic prophylaxis]. Stuttgart: Wissenschaftliche Verlagsgesellschaft; 1993. German.
   Google Scholar
• Mignard JP for the Comité de Formation Continue, Association Francaise d’Urologie. [Sterilisation anddisinfection of instruments]. Progrès en Urologie. 2004;14(Suppl 1):1049–92. French.
   Google Scholar
• Classen DC, Evans RS, Pestotnik SL, Horn SD, Menlove RL, Burke JP. The timing of prophylactic administration of antibiotics and the risk of surgical-wound infection. N Engl J Med. 1992;326(5):281–6.
   PubMed Web of Science ®Google Scholar
• Kahlmeter G. Prevalence and antimicrobial susceptibility of pathogens in uncomplicated cystitis in Europe. The ECO.SENS study. Int J Antimicrob Chemother. 2003;22(Suppl 2):49–52.
   Google Scholar
• Ronald A. The etiology of urinary tract infection: traditional and emerging pathogens. Dis Mon. 2003;49(2):71–82.
   PubMed Web of Science ®Google Scholar
• EAU Guidelines on Urological Infections, 2013.
   Google Scholar
• Clark KR, Higgs MJ. Urinary infection following out-patient flexible cystoscopy. Br J Urol. 1990;66:503–5.
   PubMedGoogle Scholar
• Jimenez Cruz JF, Sanz CS, Otero G, Díaz González R, Alvarez Ruiz F, Flores N, et al. Antimicrobial prophylaxis in urethrocystoscopy. Comparative study. Actas Urol Esp. 1993;17:172–5.
   PubMedGoogle Scholar
• Wilson L, Ryan J, Thelning C, Masters J, Tuckey J. Is antibiotic prophylaxis required for flexible cystoscopy? A truncated randomized double-blind controlled trial. J Endourol. 2005;19:1006–8.
   PubMed Web of Science ®Google Scholar
• Almallah YZ, Rennie CD, Stone J, Lancashire MJ. Urinary tract infection and patient satisfaction after flexible cystoscopy and urodynamic evaluation. Urology. 2000;56:37–9.
   PubMed Web of Science ®Google Scholar
• Burke DM, Shackley DC, O’Reilly PH. The community-based morbidity of flexible cystoscopy. BJU Int. 2002;89:347–9.
   PubMed Web of Science ®Google Scholar
• Johnson MI, Merrilees D, Robson WA, Lennon T, Masters J, Orr KE, et al. Oral ciprofloxacin or trimethoprim reduces bacteriuria after flexible cystoscopy. BJU Int. 2007;100:826–9.
   PubMed Web of Science ®Google Scholar
• Cutinha PE, Potts LK, Fleet C, Rosario D, Chapple CR. Morbidity following pressure flow studies. Are prophylactic antibiotics necessary? Neurourol Urodyn. 1996;15:304–5.
   Google Scholar
• Okorocha I, Cumming G, Gould I. Female urodynamics and lower urinary tract infection. BJU Int. 2002;89:863–7.
   PubMed Web of Science ®Google Scholar
• Onur R, Ozden M, Orhan I, Kalkan A, Semercioz A. Incidence of bacteraemia after urodynamic study. J Hosp Infect. 2004;57:241–4.
   PubMed Web of Science ®Google Scholar
• Yip SK, Fung K, Pang MW, Leung P, Chan D, Sahota D. A study of female urinary tract infection caused by urodynamic investigation. Am J Obstet Gynecol. 2004;190:1234–40.
   PubMed Web of Science ®Google Scholar
• Anders K, Cardozo L, Ashman O, Khullar V. Morbidity after ambulatory urodynamics. Neurourol Urodyn. 2002;21:461–3.
   PubMed Web of Science ®Google Scholar
• Bombieri L, Dance DA, Rienhardt GW, Waterfield A, Freeman RM. Urinary tract infection after urodynamic studies in women: incidence and natural history. BJU Int. 1999;83:392–5.
   PubMed Web of Science ®Google Scholar
• Brostrom S, Jennum P, Lose G. Morbidity of urodynamic investigation in healthy women. Int Urogynecol J Pelvic Floor Dysfunct. 2002;13:182–4.
   PubMed Web of Science ®Google Scholar
• Logadottir Y, Dahlstrand C, Fall M, Knutson T, Peeker R. Invasive urodynamic studies are well tolerated by the patients and associated with a low risk of urinary tract infection. Scand J Urol Nephrol. 2001;35:459–62.
   PubMedGoogle Scholar
• Quek P, Tay LH. Morbidity and significant bacteriuria after urodynamic studies. Ann Acad Med Singapore. 2004;33:754–7.
   PubMed Web of Science ®Google Scholar
• Porru D, Madeddu G, Campus G, Montisci I, Scarpa RM, Usai E. Evaluation of morbidity of multi-channel pressure- flow studies. Neurourol Urodyn. 1999;18:647–52.
   PubMed Web of Science ®Google Scholar
• Latthe PM, Foon R, Toozs-Hobson P. Prophylactic antibiotics in urodynamics: a systematic review of effectiveness and safety. Neurol Urodyn. 2008;27:167–73.
   PubMed Web of Science ®Google Scholar
• Cundiff GW, McLennan MT, Bent AE. Randomized trial of antibiotic prophylaxis for combined urodynamics and cystourethroscopy. Obstet Gynecol. 1999;93(Pt 1):749–52.
   PubMedGoogle Scholar
• Wein AJ, Kavoussi LR, Novick AC, Partin AW, Peters CA. Campbell-Walsh urology. 10th ed. Philadelphia, PA: Saunders; 2011.
   Google Scholar
• Crawford ED, Haynes AL Jr, Story MW, Borden TA. Prevention of urinary tract infection and sepsis following transrectal prostatic biopsy. J Urol. 1982;127:449–51.
   PubMed Web of Science ®Google Scholar
• Melekos MD. Efficacy of prophylactic antimicrobial regimens in preventing infectious complications after transrectal biopsy of the prostate. Int Urol Nephrol. 1990;22:257–62.
   PubMedGoogle Scholar
• Enlund AL, Varenhorst E. Morbidity of ultrasound-guided transrectal core biopsy of the prostate without prophylactic antibiotic therapy. A prospective study in 415 cases. Br J Urol. 1997;79:777–80.
   PubMedGoogle Scholar
• Larsson P, Norming U, Tornblom M, Gustafsson O. Antibiotic prophylaxis for prostate biopsy: benefits and costs. Prostate Cancer Prostatic Dis. 1999;2:88–90.
   PubMed Web of Science ®Google Scholar
• Puig J, Darnell A, Bermudez P, Malet A, Serrate G, Bare M, et al. Transrectal ultrasound-guided prostate biopsy: is antibiotic prophylaxis necessary? Eur Radiol. 2006;16:939–43.
   PubMed Web of Science ®Google Scholar
• Kapoor DA, Klimberg IW, Malek GH, Wegenke JD, Cox CE, Patterson AL, et al. Single-dose oral ciprofloxacin versus placebo for prophylaxis during transrectal prostate biopsy. Urology. 1998;52:552–8.
   PubMed Web of Science ®Google Scholar
• Isen K, Kupeli B, Sinik Z, Sozen S, Bozkirli I. Antibiotic prophylaxis for transrectal biopsy of the prostate: a prospective randomized study of the prophylactic use of single dose oral fluoroquinolone versus trimethoprim-sulfamethoxazole. Int Urol Nephrol. 1999;31:491–5.
   PubMedGoogle Scholar
• Aron M, Rajeev TP, Gupta NP. Antibiotic prophylaxis for transrectal needle biopsy of the prostate: a randomized controlled study. BJU Int. 2000;85:682–5.
   PubMed Web of Science ®Google Scholar
• Sabbagh R, McCormack M, Peloquin F, Faucher R, Perreault JP, Perrotte P, et al. A prospective randomized trial of 1-day versus 3-day antibiotic prophylaxis for transrectal ultrasound guided prostate biopsy. Can J Urol. 2004;11:2216–9.
   PubMedGoogle Scholar
• Schaeffer AJ, Montorsi F, Scattoni V, Perroncel R, Song J, Haverstock DC, et al. Comparison of a 3-day with a 1-day regimen of an extended-release formulation of ciprofloxacin as antimicrobial prophylaxis for patients undergoing transrectal needle biopsy of the prostate. BJU Int. 2007;100:51–7.
   PubMed Web of Science ®Google Scholar
• Lindstedt S, Lindstrom U, Ljunggren E, Wullt B, Grabe M. Single-dose antibiotic prophylaxis in core prostate biopsy: Impact of timing and identification of risk factors. Eur Urol. 2006;50:832–7.
   PubMed Web of Science ®Google Scholar
• Briffaux R, Merlet B, Normand G, Coloby P, Leremboure H, Bruyere F, et al. [Short or long schemes of antibiotic prophylaxis for prostate biopsy. A multicentre prospective randomised study]. Prog Urol. 2009;19:39–46.
   PubMed Web of Science ®Google Scholar
• Shandera KC, Thibault GP, Deshon GE Jr. Efficacy of one dose fluoroquinolone before prostate biopsy. Urology. 1998;52:641–3.
   PubMed Web of Science ®Google Scholar
• Griffith BC, Morey AF, Ali-Khan MM, Canby-Hagino E, Foley JP, Rozanski TA. Single dose levofloxacin prophylaxis for prostate biopsy in patients at low risk. J Urol. 2002;168:1021–3.
   PubMed Web of Science ®Google Scholar
• MacDermott JP, Ewing RE, Somerville JF, Gray BK. Cephradine prophylaxis in transurethral procedures for carcinoma of the bladder. Br J Urol. 1988;62:136–9.
   PubMedGoogle Scholar
• Upton JD, Das S. Prophylactic antibiotics in transurethral resection of bladder tumors: are they necessary? Urology. 1986;27:421–3.
   PubMed Web of Science ®Google Scholar
• Delavierre D, Huiban B, Fournier G, Le Gall G, Tande D, Mangin P. [The value of antibiotic prophylaxis in transurethral resection of bladder tumors. Apropos of 61 cases]. Prog Urol. 1993;3:577–82.
   PubMedGoogle Scholar
• Grabe M. Antimicrobial agents in transurethral prostatic resection. J Urol. 1987;138:245–52.
   PubMed Web of Science ®Google Scholar
• Berry A, Barratt A. Prophylactic antibiotic use in transurethral prostatic resection: a meta-analysis. J Urol. 2002;167(Pt 1):571–7.
   PubMedGoogle Scholar
• Qiang W, Jianchen W, MacDonald R, Monga M, Wilt TJ. Antibiotic prophylaxis for transurethral prostatic resection in men with preoperative urine containing less than 100,000 bacteria per ml: a systematic review. J Urol. 2005;173:1175–81.
   PubMed Web of Science ®Google Scholar
• Grasso M III. Extracorporeal shockwave lithotripsy. Available from: http://emedicine.medscape.com/article/444554-overview.
   Google Scholar
• Charton M, Vallancien G, Veillon B, Prapotnich D, Mombet A, Brisset JM. Use of antibiotics in the conjunction with extracorporeal lithotripsy. Eur Urol. 1990;17:134–8.
   PubMed Web of Science ®Google Scholar
• Deliveliotis C, Giftopoulos A, Koutsokalis G, Raptidis G, Kostakopoulos A. The necessity of prophylactic antibiotics during extracorporeal shock wave lithotripsy. Int Urol Nephrol. 1997;29:517–21.
   PubMedGoogle Scholar
• Dincel C, Ozdiler E, Ozenci H, Tazici N, Kosar A. Incidence of urinary tract infection in patients without bacteriuria undergoing SWL: comparison of stone types. J Endourol. 1998;12:1–3.
   PubMed Web of Science ®Google Scholar
• Pearle MS, Roehrborn CG. Antimicrobial prophylaxis prior to shock wave lithotripsy in patients with sterile urine before treatment: a meta-analysis and cost-effectiveness analysis. Urology. 1997;49:679–86.
   PubMed Web of Science ®Google Scholar
• Bierkens AF, Hendrikx AJ, Ezz el Din KE, de la Rosette JJ, Horrevorts A, Doesburg W, et al. The value of antibiotic prophylaxis during extracorporeal shock wave lithotripsy in the prevention of urinary tract infections in patients with urine proven sterile prior to treatment. Eur Urol. 1997;31:30–5.
   PubMed Web of Science ®Google Scholar
• Gattegno B, Sicard F, Alcaidinho D, Arnaud E, Thibault P. Extracorporeal lithotripsy and prophylactic antibiotic therapy. Ann Urol (Paris). 1988;22:101–2.
   PubMedGoogle Scholar
• Ilker Y, Tarcan T, Akdas A. When should one perform shockwave lithotripsy for lower caliceal stones? J Endourol. 1995;9:439–41.
   PubMed Web of Science ®Google Scholar
• Lu Y, Tianyong F, Ping H, Liangren L, Haichao Y, Qiang W. Antibiotic prophylaxis for shock wave lithotripsy in patients with sterile urine before treatment may be unnecessary: a systematic review and meta-analysis. J Urol. 2012;188(2):441–8.
   PubMed Web of Science ®Google Scholar
• Johnson GB, Portela D, Grasso M. Advanced ureteroscopy: wireless and sheathless. J Endourol. 2006;20(8):552–5.
   PubMed Web of Science ®Google Scholar
• Aboumarzouk OM, Kata SG, Keeley FX, Nabi G. Extracorporeal shock wave lithotripsy (ESWL) versus ureteroscopic management for ureteric calculi. Cochrane Database Syst Rev. 2011;(12):CD006029.
   Google Scholar
• Chen GL, Bagley DH. Ureteroscopic surgery for upper tract transitional-cell carcinoma: complications and management. J Endourol. 2001;15(4):399–404; discussion 409.
   PubMed Web of Science ®Google Scholar
• Lee D, Trabulsi E, McGinnis D, Strup S, Gomella LG, Bagley D. Totally endoscopic management of upper tract transitional-cell carcinoma. J Endourol. 2002;16(1):37–41.
   PubMed Web of Science ®Google Scholar
• Fourcade RO. Antibiotic prophylaxis with cefotaxime in endoscopic extraction of upper urinary tract stones: a randomized study. The Cefotaxime Cooperative Group. J Antimicrob Chemother. 1990;26(Suppl. A):77–83.
   PubMedGoogle Scholar
• Knopf HJ, Graff HJ, Schulze H. Perioperative antibiotic prophylaxis in ureteroscopic stone removal. Eur Urol. 2003;44:115–8.
   PubMed Web of Science ®Google Scholar
• Hendrikx AJ, Strijbos WE, de Knijff DW, Kums JJ, Doesburg WH, Lemmens WA. Treatment for extended-mid and distal ureteral stones: SWL or ureteroscopy? Results of a multicenter study. J Endourol. 1999;13:727–33.
   PubMed Web of Science ®Google Scholar
• Rao PN, Dube DA, Weightman NC, Oppenheim BA, Morris J. Prediction of septicemia following endourological manipulation for stones in the upper urinary tract. J Urol. 1991;146:955–60.
   PubMed Web of Science ®Google Scholar
• Charton M, Vallancien G, Veillon B, Brisset JM. Urinary tract infection in percutaneous surgery for renal calculi. J Urol. 1986;135:15–7.
   PubMed Web of Science ®Google Scholar
• Osman M, Wendt-Nordahl G, Heger K, Michel MS, Alken P, Knoll T. Percutaneous nephrolithotomy with ultrasonography-guided renal access: experience from over 300 cases. BJU Int. 2005;96(6):875–8.
   PubMed Web of Science ®Google Scholar
• Dogan HS, Sahin A, Cetinkaya Y, Akdogan B, Ozden E, Kendi S. Antibiotic prophylaxis in percutaneous nephrolithotomy: prospective study in 81 patients. J Endourol. 2002;16:649–53.
   PubMed Web of Science ®Google Scholar
• Antimicrobial resistance surveillance in Europe Annual report of the European Antimicrobial Resistance Surveillance Network (EARS-Net) 2011.
   Google Scholar